In vivo efficacy and safety of artemether–lumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018

BACKGROUND: Artemisinin-based combination therapy (ACT) has been the recommended first-line treatment for uncomplicated malaria in Mozambique since 2006, with artemether–lumefantrine (AL) and amodiaquine–artesunate (AS–AQ) as the first choice. To assess efficacy of currently used ACT, an in vivo the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nhama, Abel, Nhamússua, Lídia, Macete, Eusébio, Bassat, Quique, Salvador, Crizolgo, Enosse, Sónia, Candrinho, Baltazar, Carvalho, Eva, Nhacolo, Arsénio, Chidimatembue, Arlindo, Saifodine, Abuchahama, Zulliger, Rose, Lucchi, Naomi, Svigel, Samaly S., Moriarty, Leah F., Halsey, Eric S., Mayor, Alfredo, Aide, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487544/
https://www.ncbi.nlm.nih.gov/pubmed/34600544
http://dx.doi.org/10.1186/s12936-021-03922-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487544/
https://www.ncbi.nlm.nih.gov/pubmed/34600544
http://dx.doi.org/10.1186/s12936-021-03922-9

Ejemplares similares